Javascript must be enabled to continue!
Do Myocardial Blush Grade Following Chronic Total Occlusion Recanalization Improve Clinical Outcome of Chronic Coronary Syndromes Patients?
View through CrossRef
Background : Myocardial blush grade (MBG) is an angiographic parameter to describe the adequacy of myocardial reperfusion. The correlation between myocardial blush and the clinical outcome following chronic total occlusion (CTO) recanalization is still unclear. Our study aimed to investigate the impact of myocardial blush after CTO recanalization on the clinical outcome of CCS patients. Design : A retrospective cohort study was conducted. Patients who underwent CTO recanalization were divided into two groups based on the myocardial blush. Patients were classified as having good myocardial blush (MBG category 2 to 3 or QUBE 0 to 10.2) and poor myocardial blush (MBG category 0 to 1 or QUBE 10.2 to 36.4). The outcome measured was the improvement of angina measured using the Seattle Angina Questionnaire (SAQ) and the reduction of antianginal drug regimens. Results : The follow-up period was ranging from 2 to 24 months following the CTO recanalization procedure. The SAQ for physical limitation (83.86 ± 16.11 vs. 77.92 ± 3.44; p = 0.247), angina frequency (85.27 ± 17.44 vs. 74.76 ± 22.05; p = 0.105), and quality of life (73.24 ± 3.41 vs. 72.82 ± 3.56; p = 0.932) between the two groups was not significantly different. Good myocardial blush was not correlated with the reduction of antianginal drug regimens (10 (52.6) vs. 8 (40); p = 0.639). Conclusion : Myocardial blush post-CTO recanalization was not associated with the improvement of angina symptoms and the reduction of antianginal drug regimens among patients with CCS.
Title: Do Myocardial Blush Grade Following Chronic Total Occlusion Recanalization Improve Clinical Outcome of Chronic Coronary Syndromes Patients?
Description:
Background : Myocardial blush grade (MBG) is an angiographic parameter to describe the adequacy of myocardial reperfusion.
The correlation between myocardial blush and the clinical outcome following chronic total occlusion (CTO) recanalization is still unclear.
Our study aimed to investigate the impact of myocardial blush after CTO recanalization on the clinical outcome of CCS patients.
Design : A retrospective cohort study was conducted.
Patients who underwent CTO recanalization were divided into two groups based on the myocardial blush.
Patients were classified as having good myocardial blush (MBG category 2 to 3 or QUBE 0 to 10.
2) and poor myocardial blush (MBG category 0 to 1 or QUBE 10.
2 to 36.
4).
The outcome measured was the improvement of angina measured using the Seattle Angina Questionnaire (SAQ) and the reduction of antianginal drug regimens.
Results : The follow-up period was ranging from 2 to 24 months following the CTO recanalization procedure.
The SAQ for physical limitation (83.
86 ± 16.
11 vs.
77.
92 ± 3.
44; p = 0.
247), angina frequency (85.
27 ± 17.
44 vs.
74.
76 ± 22.
05; p = 0.
105), and quality of life (73.
24 ± 3.
41 vs.
72.
82 ± 3.
56; p = 0.
932) between the two groups was not significantly different.
Good myocardial blush was not correlated with the reduction of antianginal drug regimens (10 (52.
6) vs.
8 (40); p = 0.
639).
Conclusion : Myocardial blush post-CTO recanalization was not associated with the improvement of angina symptoms and the reduction of antianginal drug regimens among patients with CCS.
Related Results
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Abstract
Introduction
Coronary subclavian steal syndrome (CSSS) is a rare phenomenon that often goes undiagnosed and causes severe complications, including death. This report prese...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
e0543 Clinical and coronary angiography characteristics between young (<45) and old (>60) patients with coronary artery disease
e0543 Clinical and coronary angiography characteristics between young (<45) and old (>60) patients with coronary artery disease
Objective
To study the clinical Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease.
...
e0425 Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease
e0425 Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease
Objective
To study the clinical Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease.
...
Endovascular Treatment of Acute Embolism of the Major Cerebral Arteries
Endovascular Treatment of Acute Embolism of the Major Cerebral Arteries
This study evaluated: 1) the effect of recanalization on changing clinical outcome, 2) the relationship between dose of Urokinase (UK) and incidence of recanalization and intracran...
Management of Lower Limb Varicose Veins Using Endovenous Laser Ablation, Micro-Phlebectomy, and Sclerotherapy Using Multimodal Analgesia
Management of Lower Limb Varicose Veins Using Endovenous Laser Ablation, Micro-Phlebectomy, and Sclerotherapy Using Multimodal Analgesia
Abstract
Introduction
Previously, the conventional surgical procedure of high-ligation and saphenous stripping was commonly used to treat varicose veins (VVs). However, contemporar...
Extravasal compression of distal coronary arteries in immobilizing interstitial fibrosis of the heart – Shevchenko-Brado angiographic symptom complex
Extravasal compression of distal coronary arteries in immobilizing interstitial fibrosis of the heart – Shevchenko-Brado angiographic symptom complex
Heart failure is usually based on damage to cardiomyocytes. At the same time, the most common cause of myocardial dysfunction is coronary heart disease (CHD), various inflammatory ...

